A
Albireo Pharma Inc
F:BDQM
Albireo Pharma Inc
F:BDQM
Price:
41.41
EUR
0.46%
Market Closed
Market Cap:
€857.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Albireo Pharma Inc
F:BDQM
|
US |
|
Uscom Ltd
ASX:UCM
|
AU |
|
Litalico Inc
TSE:7366
|
JP |
|
DCC PLC
LSE:DCC
|
IE |
|
CG Power and Industrial Solutions Ltd
NSE:CGPOWER
|
IN |
|
Escorts Kubota Ltd
BSE:500495
|
IN |
|
R
|
Renco Holdings Group Ltd
HKEX:2323
|
HK |
|
Sacyr SA
MAD:SCYR
|
ES |
|
A
|
Aker Horizons ASA
OSE:AKH
|
NO |
|
S
|
Song Da No 11 JSC
VN:SJE
|
VN |
|
P
|
Poona Dal and Oil Industries Ltd
BSE:519359
|
IN |
|
A
|
Alok Industries Ltd
NSE:ALOKINDS
|
IN |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of BDQM.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BDQM
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
BDQM Competitors Multiples
Albireo Pharma Inc Competitors
Albireo Pharma Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
A
|
Albireo Pharma Inc
F:BDQM
|
856.9m EUR | 17.6 | -7.7 | -6.4 | -6.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
366.3B USD | 6.1 | 89.2 | 14.8 | 20.5 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.4B USD | 6.2 | -96.2 | 951.3 | -107.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.8B USD | 5.2 | 24.7 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.6B USD | 5.8 | 20 | 12.5 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.6B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80B USD | 5.6 | 17.8 | 13.2 | 15.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68B AUD | 3.2 | 35.3 | 11.6 | 14.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
